Currently Recruiting
9 drug trials actively seeking PKD patients. Links go directly to ClinicalTrials.gov enrollment pages.
How to enroll in a clinical trial
Click the "View on ClinicalTrials.gov" link for any trial below to see eligibility criteria, locations, and contact information. Always discuss participation with your nephrologist first.
Drug Trials Enrolling Patients (9)
Click "View on ClinicalTrials.gov" for eligibility criteria, locations, and contact information
Undisclosed mechanism; IV infusion every 4 weeks for 92 weeks
SGLT2 inhibitor
SGLT2 inhibitor
Oral small molecule
AMPK activator
Peptide-PMO conjugate antisense therapy targeting PKD1 mutations, delivered IV
GLP-1/GIP dual receptor agonist
Oral small molecule
Disclaimer: Enrollment links direct to ClinicalTrials.gov, where you can find full eligibility criteria and site locations. Meeting eligibility criteria does not guarantee enrollment. Always consult your nephrologist before participating in a clinical trial.